Antiviral indoleoxoacetyl piperazine derivatives

作者: Kap-Sun Yeung , Pin-Fang Lin , Milind Deshpande , Haiquan Fang , Zhongxing Zhang

DOI:

关键词: PiperazineAcquired immunodeficiency syndrome (AIDS)ChemistryDrugVirologyPharmacologyHIV Entry InhibitorsHuman immunodeficiency virus (HIV)

摘要: Abstract not available for EP1105135Abstract of corresponding document: WO0076521This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions method use. In particular, the is concerned with indoleoxoacetyl piperazine derivatives. These possess unique antiviral activity, whether used alone or in combination other antivirals, antiinfectives, immunomodulators HIV entry inhibitors. More particularly, present relates to treatment AIDS.

参考文章(36)
Brendan A. Larder, Raymond F. Schinazi, John W. Mellors, Mutations in Retroviral Genes Associated with Drug Resistance ,(1996)
Roy M. Gulick, Current antiretroviral therapy: an overview Quality of Life Research. ,vol. 6, pp. 471- 474 ,(1997) , 10.1023/A:1018447829842
Richard M. Eglen, William L. Smith, Klaus K. Weinhardt, Robin D. Clark, Joseph M. Muchowski, Serotonergic alpha-oxoacetamides ,(1990)
Paul C. Unangst, David T. Connor, Diane H. Boschelli, Indole-2-carboxamides as inhibitors of cell adhesion ,(1993)
T J Dueweke, F J Kézdy, G A Waszak, M R Deibel, W G Tarpley, The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase. Journal of Biological Chemistry. ,vol. 267, pp. 27- 30 ,(1992) , 10.1016/S0021-9258(18)48451-7
Hamideh Zarrinmayeh, Philip A. Hipskind, Donald R. Gehlert, James A. Nixon, Dennis M. Zimmerman, Karen L. Lobb, Paul L. Ornstein, Edward C. R. Smith, Thomas C. Britton, Robert F. Bruns, Indolyl neuropeptide Y receptor antagonists ,(1996)
Richard Charles Thomas, Donna Lee Romero, Substituted indoles as anti-aids pharmaceuticals. ,(1992)
William J. Greenlee, P. C. Srinivasan, HIV reverse transcriptase ,(1991)
Stephen Morris-Jones, Graeme Moyle, Philippa J Easterbrook, Antiretroviral therapies in HIV-1 infection. Expert Opinion on Investigational Drugs. ,vol. 6, pp. 1049- 1061 ,(1997) , 10.1517/13543784.6.8.1049
Owen S. Weislow, Rebecca Kiser, Donald L. Fine, John Bader, Robert H. Shoemaker, Michael R. Boyd, New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity Journal of the National Cancer Institute. ,vol. 81, pp. 577- 586 ,(1989) , 10.1093/JNCI/81.8.577